Characterization of the protective and therapeutic efficiency of a DNA vaccine encoding the major birch pollen allergen Bet v 1a.
about
Protective effect of the DNA vaccine encoding the major house dust mite allergens on allergic inflammation in the murine model of house dust mite allergy.Polymeric Materials for Gene Delivery and DNA VaccinationA DNA vaccine encoding a chimeric allergen derived from major group 1 allergens of dust mite can be used for specific immunotherapy.DNA vaccines and allergic diseases.Maternal immunization to modulate the development of allergic response and pathogen infections.Immunotherapy in asthma.Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches.For t 2 DNA vaccine prevents Forcipomyia taiwana (biting midge) allergy in a mouse model.Inhibition of type I allergic responses with nanogram doses of replicon-based DNA vaccines.Hypoallergenic derivatives of Fel d 1 obtained by rational reassembly for allergy vaccination and tolerance induction.Clustering of conformational IgE epitopes on the major dog allergen Can f 1.Next generation immunotherapy for tree pollen allergies.Recombinant DNA immunotherapy ameliorate established airway allergy in a IL-10 dependent pathway.Enhanced Prophylactic and Therapeutic Effects of Polylysine-Modified Ara h 2 DNA Vaccine in a Mouse Model of Peanut Allergy.Prevention and treatment of DNA vaccine encoding cockroach allergen Bla g 1 in a mouse model of allergic airway inflammation.Recombinant monoclonal human immunoglobulin E to investigate the allergenic activity of major grass pollen allergen Phl p 5.Characterization of Der p 21, a new important allergen derived from the gut of house dust mites.
P2860
Q25256877-18756824-F1D0-4502-BF53-8148130F9F34Q33565296-C023BA94-8B31-430D-9A96-13749A892D96Q34371132-7A981042-536F-4AFA-8176-0197E0094803Q36478858-E32A081A-8DD4-4E00-8361-FAD911ADD984Q37773283-07B83E19-6AAE-4626-A74D-2AF03F6E9583Q37793242-EB1A4A9C-C0DF-400D-8906-27EB556C944DQ38013789-B6A13EF8-1102-4ECD-BBB6-10F682FCAA2DQ38926808-29D666BE-E724-465D-B8AA-21B4D88CDD47Q40263989-0D894A17-CF87-48F4-AB41-9CFF69987FEFQ42143464-3DC2681D-3972-44BD-A161-5CD5641C5152Q42252694-7255E9AB-3126-4479-AAA0-BAFE18E6462DQ47884083-54DF1033-9B6D-45FF-B407-11A8DDCE2C46Q50507569-40DF9F48-314B-4409-BEF0-51C6B2BD180DQ51220473-6C78DCC9-49C3-490F-ABFD-1F43A87CFCE9Q52728324-91A3076E-BDCB-43E9-B7A8-8E1C248903E6Q53284669-62AD2B7A-3F57-41C7-B1DC-23E818862F12Q54423127-F2F52AB9-D568-41AA-81D9-2A6C12AFCF31
P2860
Characterization of the protective and therapeutic efficiency of a DNA vaccine encoding the major birch pollen allergen Bet v 1a.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Characterization of the protec ...... irch pollen allergen Bet v 1a.
@en
Characterization of the protec ...... irch pollen allergen Bet v 1a.
@nl
type
label
Characterization of the protec ...... irch pollen allergen Bet v 1a.
@en
Characterization of the protec ...... irch pollen allergen Bet v 1a.
@nl
prefLabel
Characterization of the protec ...... irch pollen allergen Bet v 1a.
@en
Characterization of the protec ...... irch pollen allergen Bet v 1a.
@nl
P2093
P2860
P1433
P1476
Characterization of the protec ...... irch pollen allergen Bet v 1a.
@en
P2093
Hochreiter R
Stepanoska T
Thalhamer J
P2860
P356
10.1046/J.1398-9995.2003.00335.X
P577
2004-01-01T00:00:00Z